Private equity firm Samara Capital has divested its entire shareholding in a decade-old healthcare portfolio company through a secondary transaction, just a couple of months after selling three other portfolio companies to a consortium led by Asian secondaries PE investor TR Capital. The homegrown PE firm has offloaded its entire 90% ......
This is a Premium article. Please subscribe or log in to read the full story!
Here's a selection of our recent premium content.
Already a member? Click here to log in.